Morgan Stanley Maintains Overweight on Corpay, Raises Price Target to $415

Benzinga Newsdesk www.benzinga.com Positive 80.1%

Neg 0% Neu 0% Pos 80.1%

Morgan Stanley analyst Michael Infante maintains Corpay (NYSE:CPAY) with a Overweight and raises the price target from $400 to $415.